23andme Holding Co Stock Current Valuation
ME Stock | USD 3.55 0.41 13.06% |
Valuation analysis of 23Andme Holding helps investors to measure 23Andme Holding's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. The current year's Enterprise Value is expected to grow to about 5.1 B, whereas Enterprise Value Over EBITDA is forecasted to decline to (17.54). Fundamental drivers impacting 23Andme Holding's valuation include:
Price Book 0.9096 | Enterprise Value 37.8 M | Enterprise Value Ebitda (0.17) | Price Sales 0.4117 | Enterprise Value Revenue 0.1956 |
Undervalued
Today
Please note that 23Andme Holding's price fluctuation is very risky at this time. Calculation of the real value of 23Andme Holding is based on 3 months time horizon. Increasing 23Andme Holding's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the 23Andme stock is determined by what a typical buyer is willing to pay for full or partial control of 23Andme Holding Co. Since 23Andme Holding is currently traded on the exchange, buyers and sellers on that exchange determine the market value of 23Andme Stock. However, 23Andme Holding's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 3.55 | Real 3.83 | Target 4.25 | Hype 3.64 | Naive 3.24 |
The real value of 23Andme Stock, also known as its intrinsic value, is the underlying worth of 23Andme Holding Company, which is reflected in its stock price. It is based on 23Andme Holding's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of 23Andme Holding's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of 23Andme Holding Co helps investors to forecast how 23Andme stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of 23Andme Holding more accurately as focusing exclusively on 23Andme Holding's fundamentals will not take into account other important factors: 23Andme Holding Co Company Current Valuation Analysis
23Andme Holding's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current 23Andme Holding Current Valuation | 37.81 M |
Most of 23Andme Holding's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 23Andme Holding Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
23Andme Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for 23Andme Holding is extremely important. It helps to project a fair market value of 23Andme Stock properly, considering its historical fundamentals such as Current Valuation. Since 23Andme Holding's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of 23Andme Holding's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of 23Andme Holding's interrelated accounts and indicators.
Click cells to compare fundamentals
23Andme Current Valuation Historical Pattern
Today, most investors in 23Andme Holding Stock are looking for potential investment opportunities by analyzing not only static indicators but also various 23Andme Holding's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of 23Andme Holding current valuation as a starting point in their analysis.
23Andme Holding Current Valuation |
Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition |
In accordance with the recently published financial statements, 23Andme Holding Co has a Current Valuation of 37.81 M. This is 99.74% lower than that of the Biotechnology sector and 99.52% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.77% higher than that of the company.
23Andme Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 23Andme Holding's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 23Andme Holding could also be used in its relative valuation, which is a method of valuing 23Andme Holding by comparing valuation metrics of similar companies.23Andme Holding is currently under evaluation in current valuation category among its peers.
23Andme Holding ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, 23Andme Holding's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to 23Andme Holding's managers, analysts, and investors.Environmental | Governance | Social |
23Andme Fundamentals
Return On Equity | -1.54 | ||||
Return On Asset | -0.26 | ||||
Operating Margin | (1.78) % | ||||
Current Valuation | 37.81 M | ||||
Shares Outstanding | 19.01 M | ||||
Shares Owned By Insiders | 3.65 % | ||||
Shares Owned By Institutions | 33.33 % | ||||
Number Of Shares Shorted | 1.14 M | ||||
Price To Earning | (3.48) X | ||||
Price To Book | 0.91 X | ||||
Price To Sales | 0.41 X | ||||
Revenue | 219.64 M | ||||
Gross Profit | 132.94 M | ||||
EBITDA | (291.87 M) | ||||
Net Income | (666.7 M) | ||||
Cash And Equivalents | 410.89 M | ||||
Cash Per Share | 0.90 X | ||||
Total Debt | 76.52 M | ||||
Debt To Equity | 0.1 % | ||||
Current Ratio | 3.49 X | ||||
Book Value Per Share | 7.69 X | ||||
Cash Flow From Operations | (164.32 M) | ||||
Short Ratio | 4.52 X | ||||
Earnings Per Share | (122.52) X | ||||
Target Price | 40.0 | ||||
Number Of Employees | 560 | ||||
Beta | 1.26 | ||||
Market Capitalization | 82.01 M | ||||
Total Asset | 395.17 M | ||||
Retained Earnings | (2.17 B) | ||||
Working Capital | 127.98 M | ||||
Current Asset | 212.32 M | ||||
Current Liabilities | 372.61 M | ||||
Net Asset | 395.17 M |
About 23Andme Holding Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 23Andme Holding Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 23Andme Holding using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 23Andme Holding Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out 23Andme Holding Piotroski F Score and 23Andme Holding Altman Z Score analysis. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 23Andme Holding. If investors know 23Andme will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 23Andme Holding listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (122.52) | Revenue Per Share 8.224 | Quarterly Revenue Growth (0.34) | Return On Assets (0.26) | Return On Equity (1.54) |
The market value of 23Andme Holding is measured differently than its book value, which is the value of 23Andme that is recorded on the company's balance sheet. Investors also form their own opinion of 23Andme Holding's value that differs from its market value or its book value, called intrinsic value, which is 23Andme Holding's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 23Andme Holding's market value can be influenced by many factors that don't directly affect 23Andme Holding's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 23Andme Holding's value and its price as these two are different measures arrived at by different means. Investors typically determine if 23Andme Holding is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 23Andme Holding's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.